MaxWell Biosystems (MxW) will provide the technology, data analysis and expertise related to electrophysiological in vitro testing of acute retinal preparations and retinal organoids. MxW has strong expertise in HD-MEA technology and related applications. Especially the focus of HyVIS on the fovea of the retina makes high-resolution HD-MEA an ideal tool to identify and analyse responses of retinal ganglion cells
Urs Frey, PhD
HyVIS is a research project funded from the European Union’s Horizon 2020 research and innovation actions (RIA) scheme under grant agreement no. 964468.